124.40USD-2.43%Mkt Cap: 307.25B $P/E: 35.141d ago
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxi…
Industry Peers
Drug Manufacturers - General$1.02TUSDP/E 40.7
$598.96BUSDP/E 28.8
$449.63BUSDP/E 124.8
$305.65BUSDP/E 21.0
$274.33BUSDP/E 22.0
$268.08BUSDP/E 21.8
$239.58BUSDP/E 24.9
$250.52BUSDP/E 25.0
$211.34BUSDP/E 12.0
$196.55BUSDP/E 25.4
$165.39BUSDP/E 18.1
$141.06BUSDP/E 18.9
$122.85BUSDP/E 16.9
$100.06BUSDP/E 19.4
$81.94BUSDP/E 13.3
$50.52BUSD
$29.52BUSDP/E 21.5
MRV
Marvell Technology, Inc.$20.75BUSDP/E 7.7
$11.51BUSDP/E 18.0
$11.48BUSDP/E 17.9
$11.35BUSDP/E 22.7
$6.96BUSDP/E 15.4
$3.54BUSDP/E 14.5
$2.97BUSDP/E 18.1
$53.73MUSD
$38.66MUSD
ELXR
Elixxer Ltd.$9.51MUSD
FLXN
Horizon Flexible Income ETF—P/E 26.9
ROSE
DocMorris AG—
FR0000140022
SANOFITP29OCT49—
PHOO
Photocure ASA—
CELG-RI
Bristol-Myers Squibb Company Ce—
Indicators:|
Key Statistics
Company
Market Cap307.25B $
Enterprise Value358.37B $
Revenue (TTM)65.77B $
Gross Profit48.63B $
Net Income (TTM)18.25B $
Revenue/Share26.42 USD
Last Price124.40 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees73.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS58933Y1055
Valuation
P/E (Trailing)35.14
P/E (Forward)13.20
PEG11.81
EV/EBITDA12.14
EV/Revenue5.45
P/S4.79
P/B6.86
EPS (TTM)3.54
EPS (Forward)9.66
52W Range
76.6687% of range131.74
52W High131.74 USD
52W Low76.66 USD
Profitability
Gross Margin74.80%
Oper. Margin38.60%
EBITDA Margin44.88%
Profit Margin28.08%
ROE34.70%
ROA13.34%
Growth
Revenue Growth4.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF16.47B $
CapEx (TTM)4.11B $
FCF Margin21.36%
FCF Yield4.57%
Net Debt43.41B $
Net Debt/EBITDA1.47
Balance Sheet
Debt/Equity0.94
Current Ratio1.30
Quick Ratio0.70
Book Value/Sh18.58 USD
Cash/Share2.309 USD
Dividends
Fwd Div Rate3.400 USD
Trail. Div Rate3.280 USD
Div. Yield2.67%
5Y Avg Yield3.01%
Payout Ratio93.52%
Ex-Div DateJun 15, 2026
Pay DateJul 8, 2026
Splits
Last Split1048:1000
Split DateJun 3, 2021
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)134.04 USD
Upside (mean)+7.7%
Target Range100.00 USD – 155.00 USD
$100.00+7.7% to mean$155.00
# Analysts26
Ownership
Shares Out.2.47B
Float2.47B
Insiders0.06%
Institutions82.18%
Short Interest
Short Ratio2.5d
Short % Float1.27%
Short % Out.1.27%
Shares Short31.38M
Short (prev mo.)30.55M
Technical
SMA 50119.52 (+4.1%)
SMA 200109.50 (+13.6%)
Beta0.20
S&P 52W Chg18.27%
Avg Vol (30d)9.69M
Avg Vol (10d)9.37M
Technical Indicators
RSI (14)51.9
MACD1.5587
MACD Signal1.8793
MACD Hist.-0.3206
BB Upper132.41 USD
BB Middle125.03 USD
BB Lower117.65 USD
BB Width11.80%
ATR (14)3.566 USD
Vol Ratio (20d)0.55x